Synchron is a medical device company. It focuses on the development of minimally invasive neuromodulation technology solutions. It has developed an endovascular brain–computer interface to access every corner of the brain using the blood vessels. It offers switch devices to help paralysed people, such as those with amyotrophic lateral sclerosis (ALS), communicate by controlling computer cursors with their minds.
Neurotechnology holds extraordinary promise, ranging from clinical applications, such as spinal implants, to consumer healthy lifestyle devices. But it also comes with enormous risks.
How technology could transform treatment, restore independence and redefine the possibilities for millions of patients, neural interfaces.
